ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVTX Avalo Therapeutics Inc

11.80
0.00 (0.00%)
Pre Market
Last Updated: 08:45:56
Delayed by 15 minutes

Period:

Draw Mode:

Volume 27
Bid Price 11.20
Ask Price 12.39
News -
Day High

Low
3.9501

52 Week Range

High
1,130.40

Day Low
Company Name Stock Ticker Symbol Market Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 11.80 08:45:56
Open Price Low Price High Price Close Price Prev Close
11.80
Trades Volume Avg Volume 52 Week Range
12 27 - 3.9501 - 1,130.40
Last Trade Time Type Quantity Stock Price Currency
09:01:07 1 $ 11.77 USD

Avalo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.35M 801.61k - 1.92M -31.54M -39.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avalo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AVTX Message Board. Create One! See More Posts on AVTX Message Board See More Message Board Posts

Historical AVTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.3612.4810.3011.4518,3040.443.87%
1 Month10.6313.239.9811.5717,2091.1711.01%
3 Months18.6834.468.917420.58685,842-6.88-36.83%
6 Months11.44834.463.950113.791,416,0670.3523.07%
1 Year955.201,130.403.950132.9223,394,159-943.40-98.76%
3 Years688.801,711.203.950139.338,485,869-677.00-98.29%
5 Years688.801,711.203.950139.338,485,869-677.00-98.29%

Avalo Therapeutics Description

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Your Recent History

Delayed Upgrade Clock